AT387220B - Verfahren zur herstellung von aminocyclopentansaeuren - Google Patents
Verfahren zur herstellung von aminocyclopentansaeurenInfo
- Publication number
- AT387220B AT387220B AT0381083A AT381083A AT387220B AT 387220 B AT387220 B AT 387220B AT 0381083 A AT0381083 A AT 0381083A AT 381083 A AT381083 A AT 381083A AT 387220 B AT387220 B AT 387220B
- Authority
- AT
- Austria
- Prior art keywords
- aminocyclopentane
- acids
- producing
- producing aminocyclopentane
- aminocyclopentane acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C07D295/116—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings with the doubly bound oxygen or sulfur atoms directly attached to a carbocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8230770 | 1982-10-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT387220B true AT387220B (de) | 1988-12-27 |
Family
ID=10533883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0381083A AT387220B (de) | 1982-10-28 | 1983-10-27 | Verfahren zur herstellung von aminocyclopentansaeuren |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5164503A (de) |
| JP (1) | JPS59130282A (de) |
| KR (1) | KR910005705B1 (de) |
| AT (1) | AT387220B (de) |
| AU (1) | AU567307B2 (de) |
| CA (1) | CA1191136A (de) |
| CH (1) | CH666895A5 (de) |
| DE (1) | DE3339019A1 (de) |
| DK (1) | DK492683A (de) |
| ES (1) | ES526813A0 (de) |
| FI (1) | FI76328C (de) |
| FR (1) | FR2535322B1 (de) |
| GB (1) | GB2129796B (de) |
| IT (1) | IT1170545B (de) |
| NZ (1) | NZ206077A (de) |
| ZA (1) | ZA838018B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU576476B2 (en) * | 1982-09-16 | 1988-09-01 | Glaxo Group Limited | Piperidinylcyclopentanol heptenoic acid salt |
| GB2167402A (en) * | 1984-10-26 | 1986-05-29 | Glaxo Group Ltd | Prostanoid aminocyclopentane alkenamides, their preparation and pharmaceutical formulation |
| GB2167404A (en) * | 1984-10-26 | 1986-05-29 | Glaxo Group Ltd | Prostanoid aminocyclopentane alkenoic acids and esters, their preparation and pharmaceutical formulation |
| GB8601985D0 (en) * | 1986-01-28 | 1986-03-05 | Glaxo Group Ltd | Chemical process |
| GB8715333D0 (en) * | 1987-06-30 | 1987-08-05 | Glaxo Group Ltd | Process |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2075503A (en) * | 1980-04-30 | 1981-11-18 | Glaxo Group Ltd | Prostanoid aminocyclopentane alkenoic acids and esters and their preparation and pharmaceutical formulation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU542949B2 (en) * | 1980-01-09 | 1985-03-28 | Glaxo Group Limited | Prostanoid compounds |
| JPS57183772A (en) * | 1981-04-29 | 1982-11-12 | Glaxo Group Ltd | Aminocyclopentanol acids and esters, manufacture and medicinal composition |
-
1983
- 1983-10-27 CA CA000439889A patent/CA1191136A/en not_active Expired
- 1983-10-27 DE DE19833339019 patent/DE3339019A1/de not_active Ceased
- 1983-10-27 DK DK492683A patent/DK492683A/da not_active Application Discontinuation
- 1983-10-27 AT AT0381083A patent/AT387220B/de not_active IP Right Cessation
- 1983-10-27 FI FI833930A patent/FI76328C/fi not_active IP Right Cessation
- 1983-10-27 ES ES526813A patent/ES526813A0/es active Granted
- 1983-10-27 GB GB08328747A patent/GB2129796B/en not_active Expired
- 1983-10-27 JP JP58201886A patent/JPS59130282A/ja active Granted
- 1983-10-27 AU AU20630/83A patent/AU567307B2/en not_active Ceased
- 1983-10-27 NZ NZ206077A patent/NZ206077A/en unknown
- 1983-10-27 ZA ZA838018A patent/ZA838018B/xx unknown
- 1983-10-27 FR FR8317149A patent/FR2535322B1/fr not_active Expired
- 1983-10-27 KR KR1019830005092A patent/KR910005705B1/ko not_active IP Right Cessation
- 1983-10-27 IT IT49230/83A patent/IT1170545B/it active
- 1983-10-27 CH CH5827/83A patent/CH666895A5/de not_active IP Right Cessation
-
1991
- 1991-05-13 US US07/698,895 patent/US5164503A/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2075503A (en) * | 1980-04-30 | 1981-11-18 | Glaxo Group Ltd | Prostanoid aminocyclopentane alkenoic acids and esters and their preparation and pharmaceutical formulation |
Also Published As
| Publication number | Publication date |
|---|---|
| DK492683A (da) | 1984-04-29 |
| GB2129796B (en) | 1985-09-25 |
| US5164503A (en) | 1992-11-17 |
| CA1191136A (en) | 1985-07-30 |
| KR910005705B1 (ko) | 1991-08-02 |
| GB2129796A (en) | 1984-05-23 |
| ES8504708A1 (es) | 1985-04-16 |
| DK492683D0 (da) | 1983-10-27 |
| DE3339019A1 (de) | 1984-05-03 |
| ZA838018B (en) | 1984-06-27 |
| IT8349230A0 (it) | 1983-10-27 |
| IT1170545B (it) | 1987-06-03 |
| FI76328C (fi) | 1988-10-10 |
| JPS59130282A (ja) | 1984-07-26 |
| FR2535322A1 (fr) | 1984-05-04 |
| AU567307B2 (en) | 1987-11-19 |
| ES526813A0 (es) | 1985-04-16 |
| FI76328B (fi) | 1988-06-30 |
| FR2535322B1 (fr) | 1987-01-30 |
| GB8328747D0 (en) | 1983-11-30 |
| NZ206077A (en) | 1986-09-10 |
| CH666895A5 (de) | 1988-08-31 |
| JPH0341468B2 (de) | 1991-06-24 |
| FI833930A (fi) | 1984-04-29 |
| FI833930A0 (fi) | 1983-10-27 |
| AU2063083A (en) | 1984-05-03 |
| KR840006343A (ko) | 1984-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT383808B (de) | Verfahren zur herstellung von penemen | |
| AT379615B (de) | Verfahren zur herstellung von l-carnitin | |
| AT377259B (de) | Verfahren zur herstellung von dihydropyridylimidatestern | |
| AT374827B (de) | Verfahren zur herstellung von cholesterase | |
| AT389512B (de) | Verfahren zur herstellung von 3-chlormethylchinuclidin | |
| AT367436B (de) | Verfahren zur herstellung von copolymerisaten | |
| ATA199684A (de) | Verfahren zur herstellung von 6-deoxyanthracyclinonen | |
| AT372675B (de) | Verfahren zur herstellung von alpha-cyanophenoxybenzylestern | |
| AT387220B (de) | Verfahren zur herstellung von aminocyclopentansaeuren | |
| AT387770B (de) | Verbessertes verfahren zur herstellung von trichlorisocyanursaeure | |
| AT380686B (de) | Verfahren zur herstellung von buspiron | |
| AT380480B (de) | Verfahren zur herstellung von anthracyclinglykosiden | |
| AT382141B (de) | Verfahren zur herstellung von forsteritsteinen | |
| AT372676B (de) | Verfahren zur herstellung von alpha-cyanophenoxybenzylestern | |
| DD209438A5 (de) | Verfahren zur herstellung von substituierten chloracetaniliden | |
| AT375328B (de) | Verfahren zur herstellung von sintermagnesia | |
| AT388374B (de) | Verfahren zur herstellung von n-sulfonylaryloxybenzamiden | |
| ATA201283A (de) | Verfahren zur herstellung von carboxyalkyldipeptiden | |
| ATA319282A (de) | Verfahren zur herstellung von reinem 3-amino-crotonitril | |
| AT387012B (de) | Verfahren zur herstellung von nitromethan | |
| AT384024B (de) | Verfahren zur herstellung von azinomethylrifamycinen | |
| ATA110780A (de) | Verfahren zur herstellung von o-trimethylsilyl- -cellulosen | |
| ATA193182A (de) | Verfahren zur herstellung von luftreifen | |
| AT385187B (de) | Verfahren zur herstellung von schuhwerk | |
| ATA535581A (de) | Verfahren zur herstellung von aminosûuren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |